Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells

Fig. 4

Validation of AQP9 and ZAP70 expression in laryngeal cancer. A, B RT-qPCR for expression of AQP9 and ZAP70 in each laryngeal cancer sample. C, D RT-qPCR for expression of AQP9 and ZAP70 in laryngeal cancer and normal tissues. E, F ROC curves of AQP9 and ZAP70 expression for assessing the diagnostic value of their expression. G-J Immunohistochemistry analysis of expression of AQP9 and ZAP70 in laryngeal cancer and normal tissues. Scale bar, 50 μm. K, L RT-qPCR for expression of AQP9 and ZAP70 in HaCaT, TU212 and LCC cells. M-P Immunohistochemistry analysis of expression of AQP9 and ZAP70 in HaCaT, TU212 and LCC cells. Scale bar, 50 μm. *P < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us